Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.

Opsoclonus-myoclonus-ataxia syndrome is a heterogeneous constellation of symptoms ranging from full combination of these three neurological findings to varying degrees of isolated individual sign. Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered. As a neuro-inflammatory disorder, one would expect to observe opsoclonus-myoclonus syndrome after a prevalent viral infection in a pandemic scale, as it has been the case for many other neuro-inflammatory syndromes. We report seven cases of opsoclonus-myoclonus syndrome presumably parainfectious in nature and discuss their phenomenology, their possible pathophysiological relationship to COVID-19, and diagnostic and treatment strategy in each case. Finally, we review the relevant data in the literature regarding the opsoclonus-myoclonus syndrome and possible similar cases associated with COVID-19 and its diagnostic importance for clinicians in various fields of medicine encountering COVID-19 patients and its complications.

Laboratory investigation of steam transmission in unsaturated clayey soil under osmotic potential.

Liquids coming from different sources like wastewaters, agricultural and industrial activities and leakages of chemical substances often have high concentration of chemical compositions and the osmotic gradient generated around such sources causes a considerable transmission of the Contamination. The steam transmitted by non-polluted soils moves to polluted masses, causing an increase in the volume of pollution zone and movement of pollutants. Therefore, such physical and chemical processes should be taken into account in pollution transmission models. Using Crumb method, laboratory investigations were conducted on non-dispersive and dispersive clayey soil samples obtained from three areas in Zanjan Province of Iran. A simple experimental setup has been used and hereby introduced. The impact of osmotic force from salinities of 0.5, 1, and 1.5% on steam transmission in clayey soil was examined. Results indicate that for all samples between 5 to 15 days, the moisture content increased in the pollutant zone and decreased in the non-pollutant area. Also it was observed that for dispersive clayey soil, movement of steam among layers was observed to be orderly and its amount was higher than that of non-dispersive clayey soil.

A novel effect of Noscapine on patients with massive ischemic stroke: A pseudo-randomized clinical trial.

BACKGROUND: Massive ischemic stroke causes significant mortality and morbidity in stroke patients. The main treatments for massive ischemic stroke are recombinant tissue plasminogen activator (rtPA), craniotomy, and endovascular interventions. Due to destructive effects of bradykinin on the nervous system in ischemic stroke, it seems reasonable that using Noscapine as a Bradykinin antagonist may improve patients' outcome after ischemic stroke. The effect of Noscapine on massive ischemic stroke was shown by the previous pilot study by our group. This pseudo-randomized clinical trial study was designed to assess the result of the pilot study. METHODS: Patients who had clinical symptoms or computed tomography scan indicative of massive stroke (in full middle cerebral artery territory) were entered to the study. The cases received the drugs according to their turns in emergency ward (pseudo-randomized). The patient group received Noscapine, and the control group received common supportive treatments. The patients and data analyzer were blinded about the data. At the end of the study, to adjust confounding variables we used logistic regression. RESULTS: After 1-month follow-up, 16 patients in the control group and 11 patients in the case group expired (P = 0.193). Analyzing the data extracted from Rankin scale and Barthel index check lists, revealed no significant differences in the two groups. CONCLUSION: Despite the absence of significant statistical results in our study, the reduction rate of 16% for mortality rate in Noscapine recipients is clinically remarkable and motivates future studies with larger sample sizes.

A study of factors associated with cerebral venous thrombosis.

Cerebral venous thrombosis (CVT) is an uncommon but important cause of stroke. Since there are few number of studies about the factors associated with CVT, we aimed to perform a study on Iranian patients, during a 12-year period (1997-2010) and assessed the risk factors, mortality rate, symptoms and signs, imaging and seasonal distribution. This study was a retrospective cross sectional study conducted in Rasul-e-Akram Hospital of Tehran University of Medical Sciences. The hospital is a referral neurology center for west, south and east parts of the capital city. The patients' data were extracted from the documents and entered to a self-designed checklist including probable risk factors, sequels, involved venous and also demographic characteristics. From 62 patients, 85.5% of the patients were female. Most of the patients were between 25 and 35 years old. Superior sagittal sinus was involved in 35 patients. Generalized seizure in the expired group (7 patients) was significantly more than the alive group (P = 0.017). There was a significant relationship between intracranial hemorrhage and mortality rate and between the site of thrombosis and level of consciousness. There was also a significant relationship between fasting and pregnancy with seizure in these patients. Although most of the patients presented in spring and autumn, majority of the expired cases were reported in autumn. This study can help defining risk factors, symptoms, and predicting risk factors of seizure in patients with CVT. We suggest future studies based on gathering data for meta-analysis.

Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran.

BACKGROUND: Although standard first line treatment of acute promyelocytic leukemia is All trans retinoic acid (ATRA) and chemotherapy, some patients relapse and need a second line of treatment. Relapsed cases of promyelocytic leukemia can be salvaged with arsenic trioxide. METHODS: Between May 1999 and Jan. 2010, we treated 31 relapsed cases of promyelocytic leukemia with arsenic trioxide. These cases relapsed after previous treatment with ATRA and chemotherapy. We applied arsenic trioxide as 0.15 mg/kg iv infusion until complete remission. After achieving complete remission patients received 2-4 consolidation therapy in the same schedule as remission induction. RESULTS: The median age of patients was 27 years. Complete remission rate was 77.4%. We observed four mortalities during remission induction. With a median follow up of 32 months, ten more relapses occurred. Two year disease-free survival and overall survival for the entire cohort was 54.6% and 81.1%, respectively. CONCLUSION: Our result is the same as other studies. Thus, we suggest that arsenic trioxide can be used as salvage therapy in patients who relapsed. Despite a good complete remission rate, the relapse rate during the first two years of treatment is high and hematopoietic stem cell transplantation should be considered after achieving complete remission.

Diffusion-weighted imaging of the abdomen at 3 T: image quality comparison with 1.5-T magnet using 3 different imaging sequences.

OBJECTIVE: This study aimed to perform comparisons between diffusion-weighted imaging (DWI) sequences at 3 T with 1.5 T. METHODS: Thirteen healthy volunteers underwent abdominal DWI on both 3- and 1.5-T magnets using 3 sequences including breath hold without parallel imaging (PI), breath hold with PI, and free breathing with PI at b50 and b1000. Artifacts and subjective image quality scores, signal intensity, and apparent diffusion coefficient were compared. RESULTS: For breath hold without PI, higher artifact was noted at 3 T b50 compared with 1.5 T (P < 0.0001). For b50 and b1000 breath hold with PI, artifacts were not different between the magnets, but image quality was better at 3 T (P = 0.04 and P = 0.02, respectively). For b50 and b1000 free breathing sequences, artifact and image quality scores were significantly better at 1.5 T. For breath hold acquisitions, the signal-to-noise ratio of gallbladder, kidneys, and pancreas was generally higher and that of the liver was lower on 3 T. Imaging at 3 T showed significantly higher image quality and lower artifacts for breath hold with PI compared with free breathing. Most apparent diffusion coefficients were not significantly different between the 2 magnets (P > 0.05). CONCLUSIONS: Three-tesla magnets can provide good images using breath hold with PI sequence.

Effect of intravenous extracellular gadolinium based contrast medium on renal diffusion weighted images.

RATIONALE AND OBJECTIVES: The aim of this study was to compare precontrast and postcontrast renal diffusion-weighted images for signal intensity (SI), apparent diffusion coefficient (ADC), and lesion conspicuity. MATERIALS AND METHODS: In 62 patients (mean age, 54 ± 29; 29 men, 33 women) precontrast and postcontrast (0.1 mmol/kg of extracellular gadolinium-based contrast medium; mean, 3.3 ± 0.9 minutes], diffusion-weighted images at b values of 50 and 400 s/mm² were compared (3 T). The SI, signal-to-noise ratio, and ADC of the renal cortex, medulla, and lesions were measured. Lesion contrast-to-noise ratios (against the medulla and cortex) were calculated. RESULTS: Postcontrast medullary SI decreased by 50% and cortical SI decreased by 33% and 39% on images at b = 50 s/mm² and b = 400 s/mm², respectively (P < .0001). The SI and signal-to-noise ratio of lesions did not change significantly after contrast, but lesion-medullary contrast-to-noise ratio was increased by 50% at both b = 50 s/mm² and b = 400 s/mm² (P < .005 and P = .0005, respectively) following contrast. Qualitative postcontrast lesion conspicuity was improved, with average scores of 2.8 ± 0.9 for all lesions (κ = 0.7 ± 0.08) and 3.2 ± 0.9 for solid lesions (κ = 0.82 ± 0.1). The ADC of renal cortex decreased (P = .03), but the ADC of renal medulla or renal lesions did not significantly change. CONCLUSION: Postcontrast diffusion-weighted imaging causes a significant decrease in renal parenchymal signal without a significant change in lesion signal, resulting in increased lesion conspicuity.

Supraaortic arteries: contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography--feasibility study.

PURPOSE: To evaluate and compare the diagnostic image quality resulting from three contrast agent dose regimens for 3.0-T high-spatial-resolution three-dimensional magnetic resonance (MR) angiography of the supraaortic arteries. MATERIALS AND METHODS: Institutional review board approval was obtained; informed consent was waived for this HIPAA-compliant study. One hundred twenty consecutive patients who underwent 3.0-T three-dimensional high-spatial-resolution contrast material-enhanced MR angiography of the supraaortic arteries with an identical acquisition protocol were assigned to either the high-dose (0.154 mmol per kilogram of body weight), intermediate-dose (0.097 mmol/kg), or low-dose (0.047 mmol/kg) group. Two readers evaluated resulting images for arterial definition, venous contamination, and arterial stenosis. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were evaluated at six consistent sites. Statistical analysis was performed with the Kruskal-Wallis, Wilcoxon signed rank, and analysis of variance tests and the kappa coefficient. RESULTS: Readers 1 and 2 scored vascular definition as excellent or sufficient for diagnosis in 1311 of 1360 segments and in 1313 of 1360 segments in the high-dose group (kappa = 0.73), in 1321 of 1354 and in 1319 of 1354 segments in the intermediate-dose group (kappa = 0.77), and in 1322 of 1350 and in 1320 of 1350 segments in the low-dose group (kappa= 0.66), respectively. Arterial occlusive disease was detected by reader 1 in 52, 27, and 98 segments in the high-, intermediate-, and low-dose groups, respectively. Arterial occlusive disease was detected by reader 2 in 48, 25, and 100 segments in high-, intermediate-, and low-dose groups, respectively. No significant difference existed among the three groups regarding arterial definition scores (reader 1, P = .21; reader 2, P = .25) and venous contamination scores (reader 1, P = .38; reader 2, P = .35). SNRs and CNRs were lower in the low-dose group (P < .01). CONCLUSION: At 3.0 T, high-spatial-resolution MR angiography of the supraaortic arteries can be performed with contrast agent doses as low as 0.047 mmol/kg, without compromising image quality, acquisition speed, or spatial resolution. SUPPLEMENTAL MATERIAL: http://radiology.rsnajnls.org/cgi/content/full/249/3/980/DC1http://radiology.rsnajnls.org/cgi/content/full/249/3/980/DC2.

High-spatial-resolution lower extremity MR angiography at 3.0 T: contrast agent dose comparison study.

PURPOSE: To determine whether contrast material dose reduction at 3.0 T allows preserved image quality for high-spatial-resolution magnetic resonance (MR) angiography of the lower extremities. MATERIALS AND METHODS: Forty-five consecutive patients (27 men, 18 women; mean age, 64 years) underwent contrast material-enhanced MR angiography of the lower extremities at 3.0 T. A waiver of informed consent was granted by the institutional review board. Sixteen patients received high-dose (approximately 0.3 mmol/kg), 15 received intermediate-dose (approximately 0.2 mmol/kg), and 14 received low-dose (approximately 0.1 mmol/kg) gadopentetate dimeglumine during a three-station, dual-injection examination. For scoring purposes, the arterial system from the celiac trunk to the plantar arteries was divided into 34 segments. The images were retrospectively and independently evaluated by two specialized radiologists who were blinded to the patient dose groups. All studies were assessed for overall image quality and the degree of contaminating venous enhancement. Each arterial segment was scored for the quality of vessel definition, the severity of stenoses, and the presence of collateral vessels. RESULTS: More than 99% of arterial segments were found to be of diagnostic image quality by both readers in all dose groups. Generalized estimating equation analysis showed a significant difference among the three groups with regard to vessel definition (P = .019). No significant difference was found between the high- and intermediate-dose groups; however, the low-dose group had significantly better vessel definition compared with the high-dose (P = .034) and intermediate-dose (P = .015) groups. There was no significant difference among the groups in visualization of collateral vessels. Venous contamination was seen less frequently in the low-dose group, but the difference did not achieve significance. CONCLUSION: The study showed that, compared with widely used dose strategies at 1.5 T, the contrast agent dose for 3.0-T lower extremity MR angiography can be reduced multifold without compromising image quality.

Cardiac hemangioma: features on cardiovascular magnetic resonance.

We present a case of cardiac capillary hemangioma in a patient who presented with a history of recurrent episodes of syncope. Cardiovascular magnetic resonance played an important role in the diagnosis of cardiac hemangioma in our patient.

Preferred skeletal site for osteoporosis screening in high-risk populations.

OBJECTIVES: The current World Health Organization (WHO) definition of osteoporosis, which is based on densitometry of lumbar and femoral regions, is extensively used for decision-making in clinical practice. Discordance in diagnosis of osteoporosis using this definition is a known phenomenon. The aim of this study was to evaluate the impact of such discordance and to assess the diagnostic value of using one skeletal site for screening purposes as opposed to the two sites required in the WHO criteria. STUDY DESIGN: Data was collected from 4188 individuals (3848 female); mean age=53.4 years (standard deviation 11.8) referred to a community-based outpatient osteoporosis testing centre in Tehran, Iran. METHODS: Dual-energy X-ray absorptiometry (DXA) was performed on L1-L4 lumbar spine and total hip for all cases. The DXA results were categorized according to WHO criteria. Sensitivity for each site was calculated as number of cases with T-score < -2.5 at that site divided by the total number of cases with T-score < -2.5 at any site. RESULTS: Prevalence of osteoporosis diagnosis using lumbar DXA, femoral DXA, and WHO criteria (either of the sites) were 24.7%, 12.4%, and 27.8%, respectively. Sensitivity of lumbar DXA for diagnosis of osteoporosis (88.9%) was significantly higher than femoral DXA (44.6%, P<0.001); but this difference became non-significant for men > or = 60 and women > or = 70 (P=0.615 and P=0.077, respectively). Agreement of the procedures in different sites (kappa) was 0.40 (0.37 to 0.43). When proximal femur was considered as the reference, positive likelihood ratios of lumbar DXA to detect cases were 4.7 and 2.0 in younger and older groups, respectively. CONCLUSIONS: Concerning the high rate of discordance and low agreement between DXA results, the data obtained from each anatomical site cannot predict the condition of the other site. However, if use of a single assessment is intended for screening programs, public health authorities can develop different strategies for different age groups of their population. We propose lumbar DXA for the younger group (men < 60 and women < 70) and femoral densitometry for the older.